Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Depreciation & Amortization
$187.00K
Quarterly · Period ending: · USD
LCTX Depreciation & Amortization
Latest reported$187.00Kperiod ending
Latest reported$187.00Kperiod ending
LCTX Quarterly Depreciation & Amortization ($0.00 → $187.00K)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
LCTX depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 187,000 | |
| 188,000 | |
| 186,000 | |
| 178,000 | |
| 171,000 | |
| 164,000 | |
| 151,000 | |
| 141,000 | |
| 142,000 | |
| 175,000 | |
| 175,000 | |
| 176,000 | |
| 170,000 | |
| 171,000 | |
| 173,000 | |
| 193,000 | |
| 183,000 | |
| 178,000 | |
| 191,000 | |
| 199,000 | |
| 197,000 | |
| 286,000 | |
| 336,000 | |
| 449,000 | |
| 544,000 | |
| 710,000 | |
| 734,000 | |
| 761,000 | |
| 751,000 | |
| 754,000 | |
| 744,000 | |
| 805,000 | |
| 861,000 | |
| 863,000 | |
| 860,000 | |
| 831,000 | |
| 787,000 | |
| 818,000 | |
| 826,000 | |
| 891,000 | |
| 1,297,000 | |
| 1,743,000 | |
| 1,616,000 | |
| 1,578,000 | |
| 1,563,306 | |
| 1,576,694 | |
| 3,511,933 | |
| 1,639,698 | |
| 1,633,767 | |
| 1,624,943 | |
| 1,605,127 | |
| 808,988 | |
| 782,431 | |
| 755,929 | |
| 785,413 | |
| 740,607 | |
| 682,983 | |
| 624,429 | |
| 479,409 | |
| 717,387 | |
| 648,339 | |
| 521,396 | |
| 544,050 | |
| 225,172 | |
| 149,134 | |
| 10,420 | |
| 9,687 | |
| 8,488 | |
| 8,264 | |
| 8,152 | |
| 8,410 | |
| -122,438 | |
| 80,368 | |
| 50,405 | |
| -211,507 | |
| 7,047 | |
| 7,507 | |
| 7,723 | |
| -80,288 | |
| 96,458 | |
| 8,877 | |
| 1,464 | |
| 1,094 | |
| 855 | |
| 1,450 | |
| 2,975 | |
| 5,672 | |
| 8,393 | |
| 10,510 | |
| 1,024,240 | |
| 247,130 | |
| 215,337 | |
| 193,455 | |
| 154,662 | |
| 146,210 | |
| 327,016 | |
| -76,820 | |
| 110,340 | |
| 241,587 | |
| 17,989 |